Structures by: Minkov V. S.
Total: 109
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1951(6)Å b=5.5041(6)Å c=11.4271(13)Å
α=102.665(8)° β=90.998(9)° γ=107.131(9)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1897(6)Å b=5.5033(6)Å c=11.3966(13)Å
α=102.817(9)° β=91.102(9)° γ=107.100(9)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1915(6)Å b=5.5032(6)Å c=11.4110(13)Å
α=102.745(9)° β=91.059(9)° γ=107.105(9)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1850(6)Å b=5.5008(6)Å c=11.3777(12)Å
α=102.875(8)° β=91.152(9)° γ=107.075(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1788(5)Å b=5.4990(5)Å c=11.3501(11)Å
α=102.992(8)° β=91.237(8)° γ=107.058(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1785(5)Å b=5.5003(5)Å c=11.3433(11)Å
α=103.032(8)° β=91.273(8)° γ=107.054(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1725(5)Å b=5.4987(5)Å c=11.3229(11)Å
α=103.123(8)° β=91.313(8)° γ=107.030(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1741(5)Å b=5.4977(5)Å c=11.3292(11)Å
α=103.079(8)° β=91.286(8)° γ=107.046(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1707(5)Å b=5.4969(5)Å c=11.3141(11)Å
α=103.133(8)° β=91.352(8)° γ=107.033(8)°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1682(5)Å b=5.4961(5)Å c=11.3055(11)Å
α=103.162(8)° β=91.377(8)° γ=107.022(8)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66513(16)Å b=9.0127(4)Å c=9.7723(5)Å
α=109.318(4)° β=102.263(3)° γ=100.163(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66521(18)Å b=8.9987(4)Å c=9.7696(5)Å
α=109.516(4)° β=102.251(3)° γ=100.096(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66107(17)Å b=8.9574(5)Å c=9.7578(5)Å
α=109.831(5)° β=102.228(4)° γ=99.913(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66264(17)Å b=8.9788(4)Å c=9.7642(4)Å
α=109.682(4)° β=102.236(3)° γ=100.002(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.66062(16)Å b=8.9394(4)Å c=9.7525(5)Å
α=109.967(4)° β=102.224(3)° γ=99.833(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.65706(14)Å b=8.9064(4)Å c=9.7446(4)Å
α=110.208(4)° β=102.193(3)° γ=99.702(3)°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
CrystEngComm (2012) 14, 18 5943
a=5.65476(17)Å b=8.8702(4)Å c=9.7344(4)Å
α=110.377(4)° β=102.167(3)° γ=99.621(3)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2748(2)Å b=6.6507(3)Å c=10.4397(3)Å
α=86.836(3)° β=76.833(3)° γ=70.093(4)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2705(3)Å b=6.6419(4)Å c=10.4243(5)Å
α=86.895(4)° β=76.869(4)° γ=70.160(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2644(3)Å b=6.6233(4)Å c=10.3965(4)Å
α=87.021(4)° β=76.908(4)° γ=70.282(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2672(3)Å b=6.6328(4)Å c=10.4111(4)Å
α=86.956(4)° β=76.887(4)° γ=70.227(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2615(3)Å b=6.6145(4)Å c=10.3827(4)Å
α=87.080(4)° β=76.924(4)° γ=70.335(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2589(3)Å b=6.6056(4)Å c=10.3687(4)Å
α=87.155(4)° β=76.947(4)° γ=70.385(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2563(3)Å b=6.5980(3)Å c=10.3562(4)Å
α=87.226(4)° β=76.973(4)° γ=70.438(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2540(3)Å b=6.5904(3)Å c=10.3425(4)Å
α=87.327(4)° β=77.009(4)° γ=70.477(5)°
DL-cysteinium oxalate
C3H8NO2S,0.5(C2O4)
CrystEngComm (2012) 14, 18 5943
a=5.2521(2)Å b=6.5844(3)Å c=10.3311(2)Å
α=87.440(3)° β=77.032(3)° γ=70.505(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.08996(15)Å b=5.8843(2)Å c=6.5214(2)Å
α=96.452(3)° β=103.859(3)° γ=102.076(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.07618(15)Å b=5.8583(2)Å c=6.5043(2)Å
α=96.300(3)° β=103.661(3)° γ=102.203(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.06381(14)Å b=5.83621(18)Å c=6.4864(2)Å
α=96.162(3)° β=103.409(3)° γ=102.331(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.04324(14)Å b=5.80332(17)Å c=6.4627(2)Å
α=95.944(3)° β=103.086(3)° γ=102.516(3)°
N-Acetyl-L-Cysteine
C5H9NO3S
CrystEngComm (2012) 14, 18 5943
a=5.05300(17)Å b=5.81773(18)Å c=6.4717(2)Å
α=96.051(3)° β=103.212(3)° γ=102.439(3)°
N,N-dimethylglycine
C4H9NO2,H2O2
CrystEngComm (2014) 16, 44 10165
a=10.3838(5)Å b=5.7184(3)Å c=11.4118(7)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-hydroxydimethylglycine
C4H9NO3
CrystEngComm (2014) 16, 44 10165
a=5.5044(7)Å b=10.0817(8)Å c=10.2203(13)Å
α=90.00° β=93.142(10)° γ=90.00°
N,N,N-hydroxydimethylglycine
C4H9NO3,O2H2
CrystEngComm (2014) 16, 44 10165
a=12.3320(4)Å b=9.9903(3)Å c=5.80218(16)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.7285(4)Å b=7.9107(7)Å c=8.6056(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.7099(4)Å b=7.9090(7)Å c=8.6098(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.6925(4)Å b=7.9071(7)Å c=8.6136(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.6768(4)Å b=7.9039(7)Å c=8.6154(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.6605(4)Å b=7.9000(7)Å c=8.6170(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5561(15)Å b=6.8446(5)Å c=6.1179(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5416(13)Å b=6.8003(4)Å c=6.0871(4)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5514(15)Å b=6.8288(5)Å c=6.1066(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5449(14)Å b=6.8144(5)Å c=6.0963(4)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5340(13)Å b=6.7770(4)Å c=6.0668(4)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=14.5314(13)Å b=6.7663(4)Å c=6.0577(4)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.8141(5)Å b=7.9189(8)Å c=8.5887(6)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.7737(5)Å b=7.9170(8)Å c=8.5989(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.7970(5)Å b=7.9162(8)Å c=8.5951(6)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Physical chemistry chemical physics : PCCP (2015) 17, 5 3534-3543
a=6.7518(4)Å b=7.9135(7)Å c=8.6022(5)Å
α=90.00° β=90.00° γ=90.00°
DL-cysteine
C3H7NO2S
CrystEngComm (2010) 12, 9 2551
a=9.6352(4)Å b=4.9435(2)Å c=12.8853(5)Å
α=90.0° β=121.808(2)° γ=90.0°
DL-cysteine
C3H7NO2S
CrystEngComm (2010) 12, 9 2551
a=9.712(5)Å b=4.9755(20)Å c=13.107(6)Å
α=90.0° β=121.849(25)° γ=90.0°
DL-homocysteine
C4H9NO2S
The journal of physical chemistry. B (2014) 118, 29 8513-8523
a=5.1838(6)Å b=5.5014(6)Å c=11.3669(12)Å
α=102.934(8)° β=91.190(9)° γ=107.073(8)°
Metacetamol hemihydrate
2(C8H9NO2),H2O
Acta Crystallographica Section C (2019) 75, 11
a=12.7626(4)Å b=6.92827(14)Å c=19.7011(4)Å
α=90° β=104.619(3)° γ=90°
Bis(<i>L</i>-cysteinium) <i>L</i>-cysteine difluoride hydrogen fluoride
2(C3H8N1O2S1),2(F),C3H7NO2S,HF
Acta Crystallographica Section C (2015) 71, 8
a=11.8730(6)Å b=5.2291(2)Å c=15.3459(9)Å
α=90.00° β=106.602(4)° γ=90.00°
Furosemide <i>N</i>,<i>N</i>-dimethylacetamide disolvate
C12H11ClN2O5S,2(C4H9NO)
Acta Crystallographica Section C (2016) 72, 12 997-1001
a=17.0284(10)Å b=7.8695(3)Å c=22.0555(15)Å
α=90° β=126.512(4)° γ=90°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=6.80762(14)Å b=7.91478(15)Å c=8.58490(17)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.5652(16)Å b=6.8755(6)Å c=6.1405(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.486(7)Å b=6.7327(4)Å c=5.9227(3)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.424(15)Å b=6.6545(8)Å c=5.8227(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.373(11)Å b=6.5671(6)Å c=5.7306(4)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.227(14)Å b=6.4177(6)Å c=5.5806(5)Å
α=90.00° β=90.00° γ=90.00°
N,N,N-trimethylglycine
C5H11NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=14.289(18)Å b=6.4819(8)Å c=5.6407(6)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=6.651(3)Å b=7.9179(4)Å c=8.6122(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=6.192(3)Å b=7.8972(4)Å c=8.6249(5)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=6.000(2)Å b=7.8498(3)Å c=8.5198(3)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=5.956(4)Å b=7.8277(8)Å c=8.4702(7)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=5.923(2)Å b=7.786(3)Å c=8.3734(4)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=5.918(2)Å b=7.7502(4)Å c=8.2755(4)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=5.9823(17)Å b=7.6367(3)Å c=7.9823(4)Å
α=90.00° β=90.00° γ=90.00°
N-methylglycine
C3H7NO2
Acta Crystallographica Section B (2014) 70, 3 517-532
a=6.0049(19)Å b=7.5908(4)Å c=7.8880(4)Å
α=90.00° β=90.00° γ=90.00°
Betaine 0.77-perhydrate 0.23-hydrate
C5H11NO2,0.77(H2O2),0.23(H2O)
Acta Crystallographica Section C (2013) 69, 4 416-420
a=9.5819(2)Å b=6.78424(14)Å c=11.7152(3)Å
α=90.00° β=90.00° γ=90.00°
Betaine 0.76-perhydrate 0.24-hydrate
C5H11NO2,0.76(H2O2),0.24(H2O)
Acta Crystallographica Section C (2013) 69, 4 416-420
a=9.49160(15)Å b=6.70620(11)Å c=11.5975(2)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>-dimethylglycine
C4H9NO2
Acta Crystallographica Section C (2012) 68, 8 o283-o287
a=11.2228(3)Å b=10.0097(3)Å c=18.7285(4)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>,<i>N</i>-dimethylglycine hemihydrate
C4H9NO2,0.5(H2O)
Acta Crystallographica Section C (2012) 68, 8 o283-o287
a=20.0403(8)Å b=10.7329(4)Å c=11.1120(5)Å
α=90.00° β=103.780(4)° γ=90.00°
L-cysteinium hemioxalate
C3H8NO2S,C2HO4
Acta Crystallographica Section C (2008) 64, 6 o344-o348
a=7.0529(11)Å b=10.2407(12)Å c=12.1199(15)Å
α=90.00° β=90.00° γ=90.00°
DL-cysteinium semioxalate
C3H8NO2S,C2HO4
Acta Crystallographica Section C (2009) 65, 5 o245-o247
a=5.6664(2)Å b=9.0149(4)Å c=9.7749(5)Å
α=109.349(4)° β=102.282(3)° γ=100.119(3)°
L-cysteinium semioxalate
C3H8NO2S,C2HO4
Acta Crystallographica Section C (2011) 67, 4 o139-o142
a=18.604(4)Å b=5.5723(6)Å c=11.270(2)Å
α=90.00° β=124.192(13)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.2209(4)Å b=10.0203(4)Å c=18.7351(8)Å
α=90.00° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.2187(2)Å b=10.0056(2)Å c=18.7300(4)Å
α=90.00° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.20949(18)Å b=9.98321(18)Å c=18.7137(3)Å
α=90.00° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.20324(19)Å b=9.96483(18)Å c=18.7053(4)Å
α=90.00° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1927(3)Å b=9.9481(3)Å c=18.6989(7)Å
α=90.406(3)° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1828(4)Å b=9.9261(5)Å c=18.6889(10)Å
α=90.679(5)° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1763(4)Å b=9.9150(6)Å c=18.6822(11)Å
α=90.912(6)° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=11.1668(4)Å b=9.8988(5)Å c=18.6714(10)Å
α=91.313(5)° β=90.00° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.4340(5)Å b=19.9056(12)Å c=9.7935(9)Å
α=90.00° β=91.884(7)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.4179(4)Å b=19.8855(12)Å c=9.7869(8)Å
α=90.00° β=91.958(7)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.4030(4)Å b=19.8661(11)Å c=9.7808(8)Å
α=90.00° β=92.048(6)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.3874(4)Å b=19.8354(11)Å c=9.7721(7)Å
α=90.00° β=92.100(6)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.3738(4)Å b=19.8094(10)Å c=9.7661(7)Å
α=90.00° β=92.152(6)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.3615(4)Å b=19.7898(10)Å c=9.7622(7)Å
α=90.00° β=92.201(6)° γ=90.00°
N,N-dimethylglycine
C4H9NO2
Crystal Growth & Design (2014) 14, 4 1851
a=5.3512(4)Å b=19.7699(9)Å c=9.7591(6)Å
α=90.00° β=92.228(5)° γ=90.00°
Sulfamethizole-4-aminobenzamide cocrystal
C9H10N4O2S2,C7H8N2O
Crystal Growth & Design (2015) 15, 7 3498
a=13.5102(6)Å b=15.2418(6)Å c=18.3238(7)Å
α=99.534(3)° β=98.720(3)° γ=90.086(3)°
Sulfamethizole-subericacid cocrystal
2(C9H10N4O2S2),C8H14O4
Crystal Growth & Design (2015) 15, 7 3498
a=10.4481(3)Å b=19.2259(5)Å c=16.5666(7)Å
α=90.00° β=90.00° γ=90.00°
Sulfamethizole-bipyridine cocrystal
C9H10N4O2S2,C10H8N2
Crystal Growth & Design (2015) 15, 7 3498
a=8.1754(7)Å b=18.6120(10)Å c=13.1690(11)Å
α=90.00° β=93.048(7)° γ=90.00°
Sulfamethizole-adipic acid cocrystal
C9H10N4O2S2,0.5(C6H10O4)
Crystal Growth & Design (2015) 15, 7 3498
a=7.9915(4)Å b=21.6918(8)Å c=8.5756(4)Å
α=90.00° β=95.737(4)° γ=90.00°
Sulfamethizole-4-aminobenzoicacid cocrystal
C9H10N4O2S2,C7H7NO2
Crystal Growth & Design (2015) 15, 7 3498
a=9.2097(3)Å b=10.8241(5)Å c=18.2910(7)Å
α=90.00° β=101.645(3)° γ=90.00°
Sulfamethizole-vanillic acid cocrystal
C9H10N4O2S2,C8H8O4
Crystal Growth & Design (2015) 15, 7 3498
a=8.1263(5)Å b=19.7763(7)Å c=12.0584(7)Å
α=90.00° β=109.396(4)° γ=90.00°
Sulfamethizole-mono-oxalate salt
C9H11N4O2S2,C2HO4
Crystal Growth & Design (2015) 15, 7 3498
a=8.0559(3)Å b=20.6543(6)Å c=8.5539(4)Å
α=90.00° β=99.903(3)° γ=90.00°
Furosemide 1,4-dioxane solvate
C12H11Cl1N2O5S1,C4H8O2
Crystal Growth & Design (2014) 14, 2 513
a=7.9759(5)Å b=10.6923(7)Å c=10.9369(7)Å
α=86.247(5)° β=79.053(5)° γ=80.548(5)°